Elisabeth Leiderman
2021
In 2021, Elisabeth Leiderman earned a total compensation of $569.9K as Former Chief Financial Officer and Head of Corporate Development at Decibel Therapeutics.
Compensation breakdown
Non-Equity Incentive Plan | $160,000 |
---|---|
Salary | $397,308 |
Other | $12,590 |
Total | $569,898 |
Leiderman received $397.3K in salary, accounting for 70% of the total pay in 2021.
Leiderman also received $160K in non-equity incentive plan and $12.6K in other compensation.
Rankings
In 2021, Elisabeth Leiderman's compensation ranked 10,437th out of 12,415 executives tracked by ExecPay. In other words, Leiderman earned more than 15.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 10,437 | 16th |
Manufacturing | 4,620 | 16th |
Chemicals And Allied Products | 2,070 | 13th |
Drugs | 1,836 | 12th |
Pharmaceutical Preparations | 1,362 | 12th |
Leiderman's colleagues
We found three more compensation records of executives who worked with Elisabeth Leiderman at Decibel Therapeutics in 2021.